USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico

USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

12.0

Avg claims per patent

-40%

5-year filing velocity

The verdict

Fondazione holds 8 US patents across 10 technology areas, rank #31,636 of 50,000 tracked assignees.

#31,636
of 50,000 US assignees by volume: Top 38%
by Innovation Score (39.3/100): 12.0
avg claims per patent: -40%
filing velocity, last 5 yrs

Portfolio overview

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico has been granted 8 US utility patents between 2015 and 2024, placing Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico at rank #31,636 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico is one of the more focused assignees in the PatentsView dataset. By volume, Fondazione sits between Focal Therapeutics Inc. (8 patents, rank #31,632) and Fourth Military Medical University (8 patents, rank #31,640) - the closest US assignees by grant volume. The composite Innovation Score of 39.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 5 in the 2015–2019 window, a -40% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's 12.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico against peers pursuing similar technology classes.

Focal Therapeutics

8
FOCI Fiber Optic…

8
Focuslight

8
FON Wireless

8
Fontanaarte S p A

8
Fostag Formenbau

8
Founder Mobile Me…

8
Fourth Military M…

8
Fondazione Irccs… ◀

8

What this shows Fondazione holds 8 patents at rank #31,636, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fondazione

By rank, the assignees closest to #31,636 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Fondazione's primary technology class.

Fondazione's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	25.0%
2016	2	25.0%
2017	1	12.5%
2020	1	12.5%
2023	1	12.5%
2024	1	12.5%

Which technologies does Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

A61G - TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES 1

C07K - PEPTIDES 1

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#31,636

Across all tracked assignees

Innovation Score

39.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico hold?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico holds 8 US granted patents filed between 2015 and 2024, spanning 10 technology areas.

What is Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's Innovation Score?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico has an Innovation Score of 39.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico focus on?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 2 patents. The company has filed patents in 10 CPC subclasses total.

Is Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patent filing rate increasing or decreasing?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's recent filing velocity is -40% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patents?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patents average 12.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Fondazione's 8 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Fondazione ranks #31,636 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.